Safety, Tolerability, PK & PD of AB-101 Following Oral Administration in Healthy and CHB Subjects.

Clinical trial NCT05960240 · COMPLETED

Trial details

NCT number: NCT05960240
Sponsor: Arbutus Biopharma Corporation
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Hepatitis b

Start date: 2023-08-30
Primary completion: 2025-12-04
Enrollment: 128

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.